Sulphite sensitivity typically causes respiratory symptoms (bronchospasm, particularly in some individuals with asthma) or gastrointestinal reactions, but there is no cross-reactivity between sulphonamide drug allergy and sulphite sensitivity
Why injection site doesn't matter for TB-500 (unlike BPC-157): TB-500 circulates through the bloodstream and migrates to areas of tissue damage - it seeks out injured tissue via actin upregulation signals
In contrast, nanomaterials can well compensate for these difficulties because of their unique advantages, among which, nanoformulations with tumor microenvironment responsiveness have good prospects for application
Back UCL (5 Feb 2025) 'GLP-1 drug shows little benefit for people with Parkinson's disease'
Non-operative management and outcomes of femoroacetabular impingement syndrome
Epigenetics Chromatin 15 (1), 12